文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

机械通气患者强化早期活动的个体化治疗效果:TEAM试验的二次分析

Individualised treatment effects of enhanced early mobilisation in mechanically ventilated patients: a secondary analysis of the TEAM trial.
PubMed 文献 · Intensive Care Med · 2025-11-24
一句话结论基于TEAM试验的机器学习模型可识别强化早期活动后死亡风险估计升高或降低的机械通气患者,但仅是估计且需进一步验证。

该研究为TEAM试验的二次分析,用因果推断与机器学习估计强化早期活动对比常规早期活动的个体化治疗效果。纳入687例来自40个中心(原文写sites)的机械通气患者,180天死亡141例(20.5%)。测试队列中预测的个体化效果从绝对降低34.0%到升高39.3%;模型预测与治疗分组的交互项显示治疗效果存在显著异质性(p=0.006)。预测反应差者更可能使用血管升压药、合并糖尿病、基线RASS评分更低。结论认为未来需要测试个体化活动策略。

要点

  • TEAM试验二次分析纳入687例机械通气患者,180天死亡141例(20.5%)。
  • 模型预测的强化早期活动个体化效果,在测试队列从死亡绝对降低34.0%到绝对升高39.3%。
  • 模型预测与治疗分组的交互项p=0.006,提示治疗效果存在显著异质性。
  • 预测对强化早期活动反应差者更可能使用血管升压药、合并糖尿病、基线RASS评分更低。
  • 作者结论:未来需要测试ICU个体化活动策略。

适用人群与场景

  • 机械通气患者,二次分析纳入TEAM试验687例,来自40个中心(原文写sites)。

研究设计与关键结果

  • 研究类型:TEAM试验的二次分析,采用因果推断方法估计个体化治疗效果,比较强化早期活动与常规早期活动。
  • 预测变量为原发表文献中的基线变量;主要终点为180天死亡。
  • 数据集按中心随机分为训练集和测试集两半;训练集中用五折交叉验证比较六种候选机器学习算法,最佳模型在测试集评估。
  • 按预测个体化效果三分位分层,反映估计获益、无效果或受害。
  • 共纳入687例患者(来自40个中心),141例(20.5%)在180天死亡。
  • 测试队列中预测的个体化效果从死亡绝对降低34.0%到绝对升高39.3%。
  • 模型预测与治疗分组的交互项显示治疗效果存在显著异质性(p=0.006)。
  • 与预测获益者相比,预测对强化早期活动反应差者更可能使用血管升压药、合并糖尿病、基线RASS评分更低。

证据类型、等级与局限

  • 证据类型:随机对照试验(TEAM试验)的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于基线特征,机器学习模型可识别强化早期活动后估计获益或受害的患者。
  • 作者结论:未来需要测试ICU个体化活动策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Benefit or harm from early mobilisation (EM) in mechanically ventilated patients may vary by individual patient characteristics. We used machine learning to predict individualised treatment effects (ITEs) in the "Early Active Mobilization during Mechanical Ventilation in the ICU" (TEAM) trial.

METHODS: This was a secondary analysis of the TEAM trial using a causal inference approach to estimate ITEs, which compared enhanced EM to usual care EM. Baseline variables in the original publication were used as predictor variables. The primary outcome was death by day 180. The dataset was randomly split into two halves (train and test) by site. In the training data, fivefold cross-validation was used to compare six candidate machine learning algorithms. The best-performing model was evaluated in the test dataset. Patients were stratified into tertiles based on predicted ITEs, reflecting estimated benefit, no effect or harm.

RESULTS: We included 687 patients from 40 sites, and 141 (20.5%) patients died by day 180. Predicted ITEs in the test cohort ranged from an absolute 34.0% reduction to a 39.3% increase in mortality with enhanced EM. The interaction term between the model predictions and treatment assignment demonstrated significant heterogeneity of treatment effect (p = 0.006). Patients predicted to respond poorly to enhanced EM therapy were more likely to receive vasopressors, have diabetes and have lower RASS scores at baseline, compared to patients predicted to have benefit.

CONCLUSION: Using baseline characteristics, a machine learning model identified patients with estimated benefit or harm with enhanced EM. Future testing of a personalised approach to mobilisation in the ICU is warranted.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Hodgson CL, Spicer AB, Broadley T, et al. Individualised treatment effects of enhanced early mobilisation in mechanically ventilated patients: a secondary analysis of the TEAM trial. Intensive Care Med. 2025. PMID: 41284015. doi:10.1007/s00134-025-08217-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。